These ASX shares can rise 25% to 100%+

Analysts think these shares could deliver big returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for big returns for your investment portfolio?

If you are, then take a look at the three ASX shares listed below that have been tipped to rise materially by analysts.

Here's what you need to know about them:

A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

AVITA Medical Inc (ASX: AVH)

Morgans sees huge upside for this ASX share over the next 12 months. In fact, the broker believes the regenerative medicine company could more than double in value from current levels.

It was very pleased with news that the US FDA has approved its Recell Go product. It is an autologous cell harvesting device, harnessing the regenerative properties of a patient's own skin to treat burn wounds and full-thickness skin defects. It commented:

AVH has received FDA approval for its automated product, RECELL Go, for use in burns and full thickness skin defects. This approval marks a significant milestone for the company, with management expecting this device to increase adoption of the technology amongst clinicians. We have made no changes to our forecasts and recommendation.

Morgans has an add rating and $6.40 price target on its shares. This implies potential upside of 115% for investors.

Champion Iron Ltd (ASX: CIA)

Analysts at Goldman Sachs think that this miner would be a great option for investors that are looking for exposure to iron ore. The broker feels its shares are undervalued at the current level and could offer major upside potential and good dividend yields. It said:

Supportive Valuation: the stock is trading at 0.8x NAV (A$8.8/sh) and ~4.4x EBITDA (NTM). Our NAV is based on a long run Fe price of ~US$105/t (real) for 65% Fe and ~US$75/t premium for DRPF above 62% Fe Index. For every ~US$10/t increase in our long run price, our CIA NAV would increase by ~A$1.5/sh.

Goldman has a buy rating and $8.80 price target on its shares. This implies potential upside of 25% for investors. In addition, it is forecasting dividend yields of 4% in FY 2025 and 6% in FY 2026.

Eagers Automotive Ltd (ASX: APE)

Another ASX share that could offer big returns is Eagers Automative. It operates one of Australia's largest auto dealership networks.

Bell Potter thinks that the company's shares have been oversold following a disappointing trading update last month. It said:

We believe this is a relatively isolated event that doesn't materially change the outlook so our investment thesis remains intact. We believe the stock looks value on a 2025 PE ratio of c.10x and a forecast yield of c.6% in 2024 and c.7% in 2025.

Its analysts have a buy rating and $13.35 price target on its shares. This implies potential upside of 32% for investors. In addition, dividend yields of 6%+ are forecast through to FY 2026.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical and Goldman Sachs Group. The Motley Fool Australia has recommended Avita Medical and Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Why this expert is calling time on Judo shares

A leading expert forecasts further headwinds for Judo’s beaten-down shares.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Brokers name 3 ASX shares to buy with gains of up to 75%

There's value to be had in these shares, the experts say.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Broker Notes

These ASX 200 stocks are tipped to rise up to 71% – Expert

These stocks offer compelling value.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Broker Notes

Are Telix shares a buy, hold or sell following results?

This exciting healthcare stock is tipped to keep rising.

Read more »

A group of hands up in the air as if signifying a hearty vote in favour of a motion.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Broker Notes

Bell Potter says these ASX shares could rise 90% to 200%

The market is undervaluing these shares according to the broker.

Read more »

Young couple at the counter of a hardware store.
Broker Notes

Up 29% since May, can Wesfarmers shares keep surging higher?

A leading analyst delivers his verdict on Wesfarmers' outperforming shares.

Read more »

A female coal miner wearing a white hardhat and orange high-vis vest holds a lump of coal and smiles.
Broker Notes

Up 20%, are Yancoal shares still a good buy right now?

A leading analyst provides his forecast for Yancoal’s outperforming shares.

Read more »